A new Eli Lilly study links Zepbound to lower healthcare costs in older adults with obesity, Biohaven and Haisco strike major ...

President Donald Trump’s administration is preparing to announce a new round of drug-pricing agreements with midsize biotech ...

The FDA has approved daraxonrasib (brand name Rasonque) for adults with metastatic pancreatic adenocarcinoma who have ...

Eli Lilly and Company announced results from a real-world study of adults over 55 with obesity or overweight showing that ...

Biohaven grants SK Biopharmaceuticals an exclusive worldwide license to its Kv7 ion channel platform, while Haisco licenses a preclinical type 2 inflammatory disease asset to newly formed Sentivera.

Most Phase 2 trials are sized on a guess seen as mathematics. You are in the trial design meeting, your biostatistician pulls up a standard power calculation, someone picks an effect size that feels ...

ACTO's co-founder on why AI trust equals compliant plus capable — and why role-specific context is what allows agents to achieve both. Over recent years, the pharmaceutical industry has generally ...

FDA approves Imaavy as the first treatment for warm autoimmune hemolytic anemia, McKesson agrees to acquire Precision ...

Evolving global expectations for CGT validation, comparability, and supply continuity elevate the need for operational and ...

K2 Therapeutics CEO Ying Huang on the drug development pipeline — and the compounding attrition rates that make FDA approval ...

Daniel Dornbusch (ddornbusch@mba2003.hbs.edu) leads the medical education team in Genentech?s Hematology Division. He previously worked for Genzyme, specializing in business, product, and corporate ...

Medicare Advantage has become a tougher business just as Costco is preparing to enter it. That apparent contradiction is what makes Costco’s partnership with SCAN Group worth wa ...